Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Hyperimmune Globulins market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Hyperimmune Globulins market. Detailed analysis of key players, along with key growth strategies adopted by Hyperimmune Globulins industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Sichuan Yuanda Shuyang
Grifols
CBPO
Emergent (Cangene)
Biotest
Kedrion
Kamada
CSL Behring
Hualan Bio
Shanghai RAAS
ADMA Biologics
CNBG
By Type:
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Others
By End-User:
Government Institutions
Private Sector
Other
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Hyperimmune Globulins Market
-
1.3 Market Segment by Type
-
1.3.1 USA Hyperimmune Globulins Market Size and Growth Rate of Hepatitis B Immunoglobulins from 2016 to 2027
-
1.3.2 USA Hyperimmune Globulins Market Size and Growth Rate of Rabies Immunoglobulins from 2016 to 2027
-
1.3.3 USA Hyperimmune Globulins Market Size and Growth Rate of Tetanus Immunoglobulins from 2016 to 2027
-
1.3.4 USA Hyperimmune Globulins Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Hyperimmune Globulins Market Size and Growth Rate of Government Institutions from 2016 to 2027
-
1.4.2 USA Hyperimmune Globulins Market Size and Growth Rate of Private Sector from 2016 to 2027
-
1.4.3 USA Hyperimmune Globulins Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Hyperimmune Globulins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Hyperimmune Globulins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Hyperimmune Globulins Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Hyperimmune Globulins Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Hyperimmune Globulins Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Hyperimmune Globulins by Major Types
-
3.4.1 Market Size and Growth Rate of Hepatitis B Immunoglobulins
-
3.4.2 Market Size and Growth Rate of Rabies Immunoglobulins
-
3.4.3 Market Size and Growth Rate of Tetanus Immunoglobulins
-
3.4.4 Market Size and Growth Rate of Others
4 Segmentation of Hyperimmune Globulins Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Hyperimmune Globulins by Major End-Users
-
4.4.1 Market Size and Growth Rate of Hyperimmune Globulins in Government Institutions
-
4.4.2 Market Size and Growth Rate of Hyperimmune Globulins in Private Sector
-
4.4.3 Market Size and Growth Rate of Hyperimmune Globulins in Other
5 Market Analysis by Regions
-
5.1 USA Hyperimmune Globulins Production Analysis by Regions
-
5.2 USA Hyperimmune Globulins Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Hyperimmune Globulins Landscape Analysis
-
6.1 West USA Hyperimmune Globulins Landscape Analysis by Major Types
-
6.2 West USA Hyperimmune Globulins Landscape Analysis by Major End-Users
7 South USA Hyperimmune Globulins Landscape Analysis
-
7.1 South USA Hyperimmune Globulins Landscape Analysis by Major Types
-
7.2 South USA Hyperimmune Globulins Landscape Analysis by Major End-Users
8 Middle West USA Hyperimmune Globulins Landscape Analysis
-
8.1 Middle West USA Hyperimmune Globulins Landscape Analysis by Major Types
-
8.2 Middle West USA Hyperimmune Globulins Landscape Analysis by Major End-Users
9 Northeast USA Hyperimmune Globulins Landscape Analysis
-
9.1 Northeast USA Hyperimmune Globulins Landscape Analysis by Major Types
-
9.2 Northeast USA Hyperimmune Globulins Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Sichuan Yuanda Shuyang
-
10.1.1 Sichuan Yuanda Shuyang Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Grifols
-
10.2.1 Grifols Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 CBPO
-
10.3.1 CBPO Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Emergent (Cangene)
-
10.4.1 Emergent (Cangene) Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Biotest
-
10.5.1 Biotest Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Kedrion
-
10.6.1 Kedrion Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Kamada
-
10.7.1 Kamada Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 CSL Behring
-
10.8.1 CSL Behring Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Hualan Bio
-
10.9.1 Hualan Bio Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Shanghai RAAS
-
10.10.1 Shanghai RAAS Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 ADMA Biologics
-
10.11.1 ADMA Biologics Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 CNBG
-
10.12.1 CNBG Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Hyperimmune Globulins Market Size and Growth Rate of Hepatitis B Immunoglobulins from 2016 to 2027
-
Figure USA Hyperimmune Globulins Market Size and Growth Rate of Rabies Immunoglobulins from 2016 to 2027
-
Figure USA Hyperimmune Globulins Market Size and Growth Rate of Tetanus Immunoglobulins from 2016 to 2027
-
Figure USA Hyperimmune Globulins Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Hyperimmune Globulins Market Size and Growth Rate of Government Institutions from 2016 to 2027
-
Figure USA Hyperimmune Globulins Market Size and Growth Rate of Private Sector from 2016 to 2027
-
Figure USA Hyperimmune Globulins Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Hyperimmune Globulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Hyperimmune Globulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Hyperimmune Globulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Hyperimmune Globulins Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Hyperimmune Globulins Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Hyperimmune Globulins
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Hyperimmune Globulins by Different Types from 2016 to 2027
-
Table Consumption Share of Hyperimmune Globulins by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Hepatitis B Immunoglobulins
-
Figure Market Size and Growth Rate of Rabies Immunoglobulins
-
Figure Market Size and Growth Rate of Tetanus Immunoglobulins
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Hyperimmune Globulins by Different End-Users from 2016 to 2027
-
Table Consumption Share of Hyperimmune Globulins by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Government Institutions
-
Figure Market Size and Growth Rate of Private Sector
-
Figure Market Size and Growth Rate of Other
-
Table USA Hyperimmune Globulins Production by Regions
-
Table USA Hyperimmune Globulins Production Share by Regions
-
Figure USA Hyperimmune Globulins Production Share by Regions in 2016
-
Figure USA Hyperimmune Globulins Production Share by Regions in 2021
-
Figure USA Hyperimmune Globulins Production Share by Regions in 2027
-
Table USA Hyperimmune Globulins Consumption by Regions
-
Table USA Hyperimmune Globulins Consumption Share by Regions
-
Figure USA Hyperimmune Globulins Consumption Share by Regions in 2016
-
Figure USA Hyperimmune Globulins Consumption Share by Regions in 2021
-
Figure USA Hyperimmune Globulins Consumption Share by Regions in 2027
-
Table West USA Hyperimmune Globulins Consumption by Types from 2016 to 2027
-
Table West USA Hyperimmune Globulins Consumption Share by Types from 2016 to 2027
-
Figure West USA Hyperimmune Globulins Consumption Share by Types in 2016
-
Figure West USA Hyperimmune Globulins Consumption Share by Types in 2021
-
Figure West USA Hyperimmune Globulins Consumption Share by Types in 2027
-
Table West USA Hyperimmune Globulins Consumption by End-Users from 2016 to 2027
-
Table West USA Hyperimmune Globulins Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Hyperimmune Globulins Consumption Share by End-Users in 2016
-
Figure West USA Hyperimmune Globulins Consumption Share by End-Users in 2021
-
Figure West USA Hyperimmune Globulins Consumption Share by End-Users in 2027
-
Table South USA Hyperimmune Globulins Consumption by Types from 2016 to 2027
-
Table South USA Hyperimmune Globulins Consumption Share by Types from 2016 to 2027
-
Figure South USA Hyperimmune Globulins Consumption Share by Types in 2016
-
Figure South USA Hyperimmune Globulins Consumption Share by Types in 2021
-
Figure South USA Hyperimmune Globulins Consumption Share by Types in 2027
-
Table South USA Hyperimmune Globulins Consumption by End-Users from 2016 to 2027
-
Table South USA Hyperimmune Globulins Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Hyperimmune Globulins Consumption Share by End-Users in 2016
-
Figure South USA Hyperimmune Globulins Consumption Share by End-Users in 2021
-
Figure South USA Hyperimmune Globulins Consumption Share by End-Users in 2027
-
Table Middle West USA Hyperimmune Globulins Consumption by Types from 2016 to 2027
-
Table Middle West USA Hyperimmune Globulins Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Hyperimmune Globulins Consumption Share by Types in 2016
-
Figure Middle West USA Hyperimmune Globulins Consumption Share by Types in 2021
-
Figure Middle West USA Hyperimmune Globulins Consumption Share by Types in 2027
-
Table Middle West USA Hyperimmune Globulins Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Hyperimmune Globulins Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Hyperimmune Globulins Consumption Share by End-Users in 2016
-
Figure Middle West USA Hyperimmune Globulins Consumption Share by End-Users in 2021
-
Figure Middle West USA Hyperimmune Globulins Consumption Share by End-Users in 2027
-
Table Northeast USA Hyperimmune Globulins Consumption by Types from 2016 to 2027
-
Table Northeast USA Hyperimmune Globulins Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Hyperimmune Globulins Consumption Share by Types in 2016
-
Figure Northeast USA Hyperimmune Globulins Consumption Share by Types in 2021
-
Figure Northeast USA Hyperimmune Globulins Consumption Share by Types in 2027
-
Table Northeast USA Hyperimmune Globulins Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Hyperimmune Globulins Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Hyperimmune Globulins Consumption Share by End-Users in 2016
-
Figure Northeast USA Hyperimmune Globulins Consumption Share by End-Users in 2021
-
Figure Northeast USA Hyperimmune Globulins Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Sichuan Yuanda Shuyang
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sichuan Yuanda Shuyang
-
Figure Sales and Growth Rate Analysis of Sichuan Yuanda Shuyang
-
Figure Revenue and Market Share Analysis of Sichuan Yuanda Shuyang
-
Table Product and Service Introduction of Sichuan Yuanda Shuyang
-
Table Company Profile and Development Status of Grifols
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Grifols
-
Figure Sales and Growth Rate Analysis of Grifols
-
Figure Revenue and Market Share Analysis of Grifols
-
Table Product and Service Introduction of Grifols
-
Table Company Profile and Development Status of CBPO
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CBPO
-
Figure Sales and Growth Rate Analysis of CBPO
-
Figure Revenue and Market Share Analysis of CBPO
-
Table Product and Service Introduction of CBPO
-
Table Company Profile and Development Status of Emergent (Cangene)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emergent (Cangene)
-
Figure Sales and Growth Rate Analysis of Emergent (Cangene)
-
Figure Revenue and Market Share Analysis of Emergent (Cangene)
-
Table Product and Service Introduction of Emergent (Cangene)
-
Table Company Profile and Development Status of Biotest
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biotest
-
Figure Sales and Growth Rate Analysis of Biotest
-
Figure Revenue and Market Share Analysis of Biotest
-
Table Product and Service Introduction of Biotest
-
Table Company Profile and Development Status of Kedrion
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kedrion
-
Figure Sales and Growth Rate Analysis of Kedrion
-
Figure Revenue and Market Share Analysis of Kedrion
-
Table Product and Service Introduction of Kedrion
-
Table Company Profile and Development Status of Kamada
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kamada
-
Figure Sales and Growth Rate Analysis of Kamada
-
Figure Revenue and Market Share Analysis of Kamada
-
Table Product and Service Introduction of Kamada
-
Table Company Profile and Development Status of CSL Behring
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL Behring
-
Figure Sales and Growth Rate Analysis of CSL Behring
-
Figure Revenue and Market Share Analysis of CSL Behring
-
Table Product and Service Introduction of CSL Behring
-
Table Company Profile and Development Status of Hualan Bio
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hualan Bio
-
Figure Sales and Growth Rate Analysis of Hualan Bio
-
Figure Revenue and Market Share Analysis of Hualan Bio
-
Table Product and Service Introduction of Hualan Bio
-
Table Company Profile and Development Status of Shanghai RAAS
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai RAAS
-
Figure Sales and Growth Rate Analysis of Shanghai RAAS
-
Figure Revenue and Market Share Analysis of Shanghai RAAS
-
Table Product and Service Introduction of Shanghai RAAS
-
Table Company Profile and Development Status of ADMA Biologics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ADMA Biologics
-
Figure Sales and Growth Rate Analysis of ADMA Biologics
-
Figure Revenue and Market Share Analysis of ADMA Biologics
-
Table Product and Service Introduction of ADMA Biologics
-
Table Company Profile and Development Status of CNBG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CNBG
-
Figure Sales and Growth Rate Analysis of CNBG
-
Figure Revenue and Market Share Analysis of CNBG
-
Table Product and Service Introduction of CNBG
-
